These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11665665)

  • 21. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.
    Balasch J; Vidal E; Peñarrubia J; Casamitjana R; Carmona F; Creus M; Fábregues F; Vanrell JA
    Hum Reprod; 2001 Aug; 16(8):1636-43. PubMed ID: 11473955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol.
    Zhao S; Xu H; Wu X; Xia L; Li J; Zhang D; Zhang A; Xu B
    Front Endocrinol (Lausanne); 2023; 14():1093954. PubMed ID: 36793280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios?
    Yang JH; Wu MY; Chao KH; Chen SU; Ho HN; Yang YS
    J Reprod Med; 1997 Oct; 42(10):663-8. PubMed ID: 9350023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation.
    Mukherjee T; Copperman AB; Lapinski R; Sandler B; Bustillo M; Grunfeld L
    Fertil Steril; 1996 Mar; 65(3):588-93. PubMed ID: 8774292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation.
    Kofinas JD; Elias RT
    Womens Health (Lond); 2014 Sep; 10(5):505-9. PubMed ID: 24807379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different follicle stimulating hormone/luteinizing hormone ratios for ovarian stimulation.
    Duijkers IJ; Vemer HM; Hollanders JM; Willemsen WN; Bastiaans LA; Hamilton CJ; Thomas CM; Borm GF
    Hum Reprod; 1993 Sep; 8(9):1387-91. PubMed ID: 8253923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
    Sullivan MW; Stewart-Akers A; Krasnow JS; Berga SL; Zeleznik AJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):228-32. PubMed ID: 9920089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome.
    Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; de Fatis CT; Pocognoli P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2659-63. PubMed ID: 10443656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.
    Ganor-Paz Y; Friedler-Mashiach Y; Ghetler Y; Hershko-Klement A; Berkovitz A; Gonen O; Shulman A; Wiser A
    J Endocrinol Invest; 2016 Jul; 39(7):799-803. PubMed ID: 26797707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IVF performance of women who have fluctuating early follicular FSH levels.
    Lass A; Gerrard A; Abusheikha N; Akagbosu F; Brinsden P
    J Assist Reprod Genet; 2000 Nov; 17(10):566-73. PubMed ID: 11209537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
    Oudshoorn SC; van Tilborg TC; Hamdine O; Torrance HL; Eijkemans MJC; Lentjes EGWM; Lambalk CB; Broekmans FJM
    Hum Reprod; 2017 Aug; 32(8):1701-1709. PubMed ID: 28854580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
    Liu KE; Greenblatt EM
    Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.
    Peñarrubia J; Fábregues F; Creus M; Manau D; Casamitjana R; Guimerá M; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2003 Dec; 18(12):2689-97. PubMed ID: 14645193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.